University of Pennsylvania
Philadelphia, Pennsylvania
Private University
Founded 1740
Penn is a major research university with strong commercialization in biomedical sciences, gene therapy, and financial technology.
55
Startups (5yr)
235
Patents Filed
178
Patents Issued
72
Licenses (5yr)
$42.0M
License Revenue
145
Partnerships
$1.3B
Research $
Research Focus Areas
Gene Therapy & Genomics
Gene editing and inherited disease treatment
Perelman School of MedicineGene Therapy Program
Biomedical Engineering
Wearables, diagnostics, and implantables
Bioengineering
Neuroscience
Brain disorders and cognitive science
Penn Neuroscience
Related Market Maps
Explore market opportunities in deep tech categories relevant to Penn's research focus.
Neurotechnology
22% CAGRTechnologies interfacing with the nervous system for medical and research applications
Market Size$15B
Biotechnology
15% CAGRApplication of biological systems and organisms to develop products and technologies
Market Size$1.2T
Notable Spinouts
Spark Therapeutics
Founded 2013 • Biotechnology
Gene therapy company for inherited diseases
$4300M exitby Roche
Programs & Resources
Tech Transfer Office
Penn Center for Innovation
IP Portfolio Available
~220 technologies available for licensing
Gene TherapyBiomedicalPharmaceuticals
Platform: Custom
Browse IP PortfolioServices Offered
- •IP management
- •Licensing
- •Startup formation
- •Industry partnerships
Interested in Tech Transfer?
Learn how to navigate university licensing and commercialization